Menu Close

Obstructive diseases and remodeling

Several lung diseases are characterized by remodeling that changes the cellular composition, reactivity and function of the affected tissues in a progressive manner in response to a pathological process and which affects pulmonary functions. This remodeling process plays a central role in chronic obstructive pulmonary disease (COPD), asthma in some forms of pulmonary hypertension, idiopathic pulmonary fibrosis and cystic fibrosis. 

Management team

Dr Mathieu Morissette PhD
Université Laval
Director of the Obstructive diseases and remodeling axis
Dr Ilan Azuelos MD
McGill University
Co-Director of the Obstructive diseases and remodeling axis
Dre Andréanne Côté
Quebec Heart and Lung Institute in Quebec
Co-Director of the Obstructive diseases and remodeling axis
Dre Roxane Paulin
Université Laval
Co-Director of the Obstructive diseases and remodeling axis
 Dr Benjamin Smith MD
McGill University
Co-Director of the Obstructive diseases and remodeling axis

All axis members